| Wednesday 11:15 AM | WE-E-BRA-1 : Advancing Radioimmunotherapy For Brain Tumors Using In Vitro Assays Y. Walter*, O. Salas, A. Benoit, D. Jordan, E. Jank, A. Hubbard, A. Ekpenyong |
| Wednesday 11:25 AM | WE-E-BRA-2 : Analysis of a Novel Concept for Intraocular Tumors - the Combination of Brachytherapy and Teletherapy H. Manke*, D. Flühs, M. Stroth, S. Müller, B. Spaan, J. Albrecht |
| Wednesday 11:35 AM | WE-E-BRA-3 : Effect of PEGylated Gold Nanoparticles in Intraoperative Radiotherapy (IORT) Dose Enhancement in the MCF-7 Human Breast Cancer Cell Line Using Gafchromic™ EBT3 Films N. Seyedpour, H. Ghanbari, E. Shaabani, F. Kalantari, S. Gholami* |
| Wednesday 11:45 AM | WE-E-BRA-4 : MRI-Only Treatment Planning (MRTP) for Interstitial Gynecologic HDR Brachytherapy C. Lee*, E. Kaza, T. Harris, D. O'Farrell, R. Cormack, I. Buzurovic |
| Wednesday 11:55 AM | WE-E-BRA-5 : Prompt Gamma-Ray Spectroscopy Validation for Real-Time Proton Range Verification S. Tattenberg*, R. Marants, K. Niepel, T. Bortfeld, A. Sudhyadhom, G. Landry, K. Parodi, J. Verburg |
| Wednesday 12:05 PM | WE-E-BRA-6 : The Stereotactic Map and Compass: How to Use AFI Strategy Optimization and R50%Analytic to Find Your Way to An Excellent SRS/SRT Plan I. Cordrey*, D. Desai |